The thalamic nucleus submedius and ventrolateral orbital cortex are involved in nociceptive modulation: a novel pain modulation pathway

Prog Neurobiol. 2009 Dec;89(4):383-9. doi: 10.1016/j.pneurobio.2009.10.002. Epub 2009 Oct 9.


Recently, a series of studies have given rise to and provided evidence for the hypothesis that the nucleus submedius (Sm) in the medial thalamus is involved in modulation of nociception. The Sm, ventrolateral orbital cortex (VLO) and the periaqueductal gray (PAG) constitute a pain modulatory pathway, activation of which leads to activation of the PAG-brainstem descending inhibitory system and depression of the nociceptive inputs in the spinal cord and trigeminal nucleus. Other studies have indicated that the Sm-VLO-PAG pathway plays an important role in the analgesia induced by electroacupuncture stimulation of the acupuncture point (acupoint) for exciting small diameter fiber (A-delta and C group) afferents. Opioid peptides, serotonin, dopamine, glutamate and their related receptors are involved in Sm- and/or VLO-mediated descending antinociception, and a GABAergic disinhibitory mechanism participates in mediating the antinociception induced by activation of mu-opioid receptors, serotonin 1(A) receptors, and dopamine D(2)-like receptors. This review describes these findings, which provide important new insights into the roles of the thalamus and cerebral cortex in descending pain modulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acupuncture Analgesia / methods
  • Animals
  • Frontal Lobe / physiopathology*
  • Humans
  • Neural Pathways / physiopathology
  • Neurons / physiology
  • Neurotransmitter Agents / metabolism
  • Nociceptors / physiology*
  • Pain / pathology*
  • Pain Management
  • Periaqueductal Gray / physiopathology
  • Receptors, Neurotransmitter / physiology
  • Thalamic Nuclei / pathology
  • Thalamic Nuclei / physiopathology*


  • Neurotransmitter Agents
  • Receptors, Neurotransmitter